Skip to main content
. 2014 Jul 30;2:910–920. doi: 10.1016/j.redox.2014.07.006

Fig. 6.

Fig. 6

nSMase3 splice variant activity. (A) Fluorescence images of GFPnSMase3a and GFPnSMase3b in myotubes (scale bar=100 µm). (B) Western blot of lysates transfected with GFPnSMase3a or b using anti-nSMase3. (C) Quantification of B (n=3), P<0.001 vs. GFPnSMase3a. (D) nSMase activity in lysates from myotubes transfected with GFPnSMase3a or GFPnSMase3b (choline release, n=6), P<0.05 vs. GFP control.

HHS Vulnerability Disclosure